Product Information

DEXTROAMP-AMPHETAMIN 20 MG TAB is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.3039 per EA under NDC 42858072601. Its NADAC has been published 230 times since Feb 2, 2022.

The Low Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Low Outlier
DEA Schedule CII

Strength

5; 5; 5; 5 mg/1; mg/1; mg/1; mg/1

NDC

42858072601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213111

On Market Since

9/9/2021

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 20 MG TAB has been published 230 times since Feb 2, 2022, and over the history we have for it it has declined 5.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3039 per EA
All-time high$0.3621 (Sep 13, 2023)
All-time low$0.2545 (Apr 17, 2024)
52-week high$0.3361
52-week low$0.3039
Median price$0.3216
Average price$0.3175
Largest weekly change+26.2% (Jun 19, 2024)
Weeks tracked230
Tracking sinceFeb 2, 2022

Price History

1W

0.0%

1M

-1.0%

3M

-1.9%

6M

-5.9%

1Y

-5.5%

3Y

-10.4%

5Y

N/A

All

-5.0%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 20 MG TAB, manufactured by Rhodes Pharmaceuticals L.P., is $0.3039 per EA (NDC 42858072601), effective Jun 24, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 20 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 20 MG TAB has declined 5.0%. It has been tracked across 230 weekly CMS publications since Feb 2, 2022.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 20 MG TAB?

Since Feb 2, 2022, the NADAC for DEXTROAMP-AMPHETAMIN 20 MG TAB has ranged from a low of $0.2545 (Apr 17, 2024) to a high of $0.3621 (Sep 13, 2023), with a median of $0.3216 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 20 MG TAB?

4 NADAC-published products share the same active ingredient, strength, and dosage form as DEXTROAMP-AMPHETAMIN 20 MG TAB, but none are currently priced below it.

Who manufactures DEXTROAMP-AMPHETAMIN 20 MG TAB?

DEXTROAMP-AMPHETAMIN 20 MG TAB (NDC 42858072601) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.